C15H17N 3 O4, triclinic, P1 (no. 2), a = 10.5986(5) Å, b = 11.5298(5) Å, c = 13.5386(6) Å, α = 102.694(1)°, β = 102.999(1)°, γ = 108.918(1)°, V = 1446.03(11) Å 3 , Z = 4, Rgt(F) = 0.0525, wR ref (F 2 ) = 0.1526, T = 100(1) K.
Mo Kα radiation (0.71073 Å) µ: 0.10 mm −1 Diffractometer, scan mode:
Bruker SMART APEX-II Duo, φ and ω θmax, completeness: 33.4°, 99% N(hkl) measured , N(hkl) unique , R int : 73858, 11136, 0.050 Criterion for I obs , N(hkl)gt: I obs > 2 σ(I obs ), 7872 N(param) refined : 419 Programs:
Bruker [1] , SHELX [2] , Spek [3] , Mercury [4] Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.
Source of material
Hydrazine hydrate (3.3 mmol) was added to a mixture of ethyl 4-hydroxy-2-(4-methoxyphenyl)-1-methyl-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate (3 mmol) and 15 mL of acetic acid. The mixture was refluxed for 3 h and cooled. The reaction mixture was evaporated under reduced pressure and [5] .
Experimental details
Data collection was performed by using the APEX2 software [1] and the cell refinement and data reduction were performed under the SAINT software [1] . The crystal structure was solved by direct method [2] and refined by fullmatrix least squares technique on F 2 using SHELXTL [2] . Absorption correction was applied to the final crystal data by using the SADABS software [1] . All geometrical calculations were carried out using the program PLATON [2] . The molecular graphics were drawn using SHELXTL [2] and Mercury [4] program. In this compound, the N-bound H atoms were located in difference Fourier maps and allowed to be refined freely [refined distance: N-H = 0.904(16)−0.976(19) Å]. The remaining hydrogen atoms were positioned geometrically [C-H = 0.95−0.99 Å] and were refined using a riding model, with U iso (H) = 1.2 Ueq(C) or 1.5 Ueq(methyl C). A rotating-group model was used for the methyl groups.
Comment
Pyrazoles play a vital role in pharmaceuticals, since they possess an interesting pharmacological profile, such as anti-inflammatory [6] , antimicrobial [7] , antiviral [8] , antitumor [9] , anticonvulsant [10] , antidepressant activities [11] and antihistaminic [12] etc. It commonly synthesized either by condensation of hydrazines with 1,3-dicarbonyl or by intermolecular cycloaddition reaction of alkynes to 3-dipoles [13] . During the course of our study, we have unexpectedly found that substituted pyrazole could be synthesized by condensation of pyrrolidine with hydrazine in acidic condition.
To the best of our knowledge; this is the first report that synthesizes substituted pyrazole from pyrrolidine ring transformation.
The asymmetric unit of the title compound consists of two crystallographically independent molecules, A and B (left part of the figure) . The bond lengths and angles are within the normal ranges and comparable to the related structures [14] [15] [16] [17] . In each molecule (A and B) , intramolecular N3A-H3NA· · · O2A and N3B-H3NB· · · O2B hydrogen bond are found, respectively, forming S(7) ring motif [18] . This interaction further stabilizes the molecular structure and locks its atoms in a nearly planar arrangement. In the independent molecule A, the 1-methoxy-4-methylbenzene (C4A-C9A/O4A/C15A) moiety is slightly twisted at C3A-C4A bond with C2A-C3A-C4A-C5A torsion angle of 44.46(19)°. Meanwhile, in molecule B the 1-methoxy-4-methylbenzene (C4B-C9B/O4B/C15B) and ethyl acetate (O2B/O3B/C12B-C14B) moieties are observed to be slightly twisted at C3B-C4B and C2B-C12B bonds, respectively. The twisted angle of C2B-C3B-C4B-C5B is found to be 67.48 (18) °while the twisted angle for C1B-C2B-C12B-O2B is −12.4(2)°(right part of the figure). In both molecules, the pyrazole rings (N1A/N2A/C1A-C3A and N1B/N2B/C1B-C3B) form dihedral angles of 41.72 (7) °and 62.81 (7) °with the phenyl rings (C4A-C9A and C4B-C9B), respectively.
